Laura Michel

6PUBLICATIONS
51CO-AUTHORS
Predictive and prognostic markersMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Oct 29, 2026
Real-Time Electronic Patient-Reported Outcome Monitoring With Digital Triage and Care-Team Integration in Early Breast Cancer: ENABLE Randomized Controlled Trial.

|Oct 28, 2026
Neuroendocrine Differentiation Mediates Escape from HER2-Targeted Therapy in Breast Cancer.

|Dec 23, 2024
Machine Learning to Predict the Individual Risk of Treatment-Relevant Toxicity for Patients With Breast Cancer Undergoing Neoadjuvant Systemic Treatment.

Lie Cai, Thomas M Deutsch, Chris Sidey-Gibbons

|Jun 10, 2020
Immune Checkpoint Blockade in Patients with Triple-Negative Breast Cancer.

Laura L Michel, Alexandra von Au, Athanasios Mavratzas

|Jun 26, 2019
Locoregional risk assessment after neoadjuvant chemotherapy in patients with primary breast cancer: clinical utility of the CPS + EG score.

Laura L Michel, Laura Sommer, Rosa González Silos

|Feb 01, 2019
Prediction of local recurrence risk after neoadjuvant chemotherapy in patients with primary breast cancer: Clinical utility of the MD Anderson Prognostic Index.

Laura L Michel, Laura Sommer, Rosa González Silos

Pageof 1

Frequent Collaborators

3 joint publications

Andreas Schneeweiss

2 joint publications

André Pfob

1 joint publications

Rosa González Silos

1 joint publications

Roberto Würth